The FDA is working to answer questions about the science, safety, and quality of products containing cannabis and cannabis-derived compounds, particularly CBD.
Potential harm, side effects and unknowns
The FDA recognizes the significant public interest in cannabis and cannabis-derived compounds, particularly CBD. However, there are many unanswered questions about the science, safety, and quality of products containing CBD. The agency is working on answering these questions through ongoing efforts including feedback from a recent FDA hearing and information and data gathering through a public docket.
Unanswered questions about the science, safety, and quality
The FDA is committed to setting sound, science-based policy. The FDA is raising these safety, marketing, and labeling concerns because we want you to know what we know. We encourage consumers to think carefully before exposing themselves, their family, or their pets, to any product, especially products like CBD, which may have potential risks, be of unknown quality, and have unproven benefits.
A 2015 review of studies in the journal Neurotherapeutics suggests that CBD might help treat anxiety disorders.
People that support the use of CBD claim that CBD oil can treat a variety of health problems, including:
CBD oil may also increase liver enzymes (a marker of liver inflammation). People with liver disease should consult their healthcare provider before taking CBD oil and use it with caution. Regular blood liver enzyme level checks are recommended.